Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis

Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden

(2014) Michelle D Holmes et al.   BMC CANCER

Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice

(2014) Liam J Murray et al.   BREAST CANCER RESEARCH

Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study

(2014) E. H. Allott et al.   BREAST CANCER RESEARCH AND TREATMENT

Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery

(2014) P. Forget et al.   BRITISH JOURNAL OF ANAESTHESIA

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study

(2014) D M Fraser et al.   BRITISH JOURNAL OF CANCER

Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I-III Breast Cancer: A Nationwide Population-Based Cohort Study

(2014) T. I. Barron et al.   CANCER RESEARCH

NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin-Aromatase Interactions

(2014) L. W. Bowers et al.   CANCER RESEARCH

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

(2013) Patrice Forget et al.   ANNALS OF SURGICAL ONCOLOGY

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

(2013) Paul E. Goss et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis

(2012) Y. Li et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

COX2 overexpression is a prognostic marker for Stage III breast cancer

(2011) Hee Sung Kim et al.   BREAST CANCER RESEARCH AND TREATMENT

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis

(2011) Myriam Labelle et al.   CANCER CELL

Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial

(2011) Louis W.C. Chow et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Aspirin Intake and Survival After Breast Cancer

(2010) Michelle D. Holmes et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors

(2010) Karen J. Wernli et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Reduced Risk of Bone Metastasis for Patients With Breast Cancer Who Use COX-2 Inhibitors

(2009) Matias E. Valsecchi et al.   Clinical Breast Cancer

Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women

(2008) A. G. Hudson et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION